Tag | Content |
---|
EnhancerAtlas ID | HS184-17254 |
Organism | Homo sapiens |
Tissue/cell | T47D |
Coordinate | chr2:208693220-208694120 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL2 | MA0478.1 | chr2:208693921-208693932 | GGATGACTCAT | + | 6.62 | JUN(var.2) | MA0489.1 | chr2:208693346-208693360 | GGGAGATGACTCAC | + | 6.02 | JUNB | MA0490.1 | chr2:208693921-208693932 | GGATGACTCAT | + | 6.62 | Rhox11 | MA0629.1 | chr2:208693977-208693994 | TGTTTTTACAGCGAAGT | - | 6.08 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_23192 | chr2:208692923-208693828 | Colon_Crypt_1 | SE_28346 | chr2:208693094-208693987 | Fetal_Intestine | SE_32146 | chr2:208693054-208693856 | Gastric |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr2 | 208693538 | 208693694 | chr2 | 208693862 | 208693970 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I207828 | chr2 | 208692781 | 208698619 |
|
Enhancer Sequence | CTGCAAAAGT CAACCATGGA TATGATGAGC AAGACTGAAG CCAGCAAGAC ACAAATGGGA 60 AGCCCTGTGG CCTCAGGTGC AGCTGGTGGC ACAATCTACT GTTCTGGACA ACCCTGCCAA 120 TGGGAAGGGA GATGACTCAC TGAAATGAAC TGTTTGTTTT TCCAAAATGC TCAAGGTTGA 180 ATTTCACTTG AAAAACATTT TTGCTTTTCT GATCTGAACT AGGGCTTATG AGTGGGGGGG 240 AGTCCGCAGT CACCCAGCAA TTCTGGTTAT AGTGACAATG GACAGAACAC CAGAAGCTCT 300 CCATTGAGAA GGGAATTGGC AGTGACTCTA GAGTGAAATG ACAGAAAATG AGAGGGGAGT 360 GCCTCGTGAA AACGCTCGGC ACACCAGTGA CAGCCACAGC GTTACATCCA TGGCGAGGCA 420 GCTTTCTACA TCAGTTAACA CGAGCTAAGT GGTTCTCTGT TAACTAGCTG CCTTTATTTG 480 ACAGTTTGAA AAGATAAAAT GACACATTTT CATTTTCTGA ATGACATCCT GTGGTCTATG 540 AAATCTTGTG AGTTTTTTAA AAATTAGGAA AAAACTCCTA CCTTTGTAAG TCTACCTTTA 600 TAACATGAGC GTGAACATTA AAGCAGGAGA CAGTGGGGAA GAAAACATTT TTCAAACAAT 660 ATGACAGATA TTGTAATATG TAGAGAGCAA ACATTCCAGG TGGATGACTC ATTTGTTGTT 720 TGGCTTGGTG GAAGCCTGCA CGGGAGTCTA AATAACTTGT TTTTACAGCG AAGTTTTTAT 780 TTATTTATTT TTTTGGAGAT AGGGTCTCAC TCTGTCACCC AGGCTGAAGT GCAGTGGTGT 840 GACCTCGGCT CACTGCACCC TCTGCCTCCT CCTGGGCTCA AGTGATCCTC CCACCTCAGC 900
|